Fuente botánica

Apigenin 7-O-(2G-rhamnosyl)gentiobioside is a flavonoid glycoside, which is a compound comprised of the flavonoid apigenin linked to a sugar moiety. This compound is typically sourced from various plants, where it occurs naturally as part of the plant's secondary metabolites. The glycoside form enhances the solubility and stability of the apigenin molecule, which is essential for its biological activities. The mode of action of Apigenin 7-O-(2G-rhamnosyl)gentiobioside involves various biological pathways. As a flavonoid, it can exhibit antioxidant properties, potentially scavenging reactive oxygen species and contributing to the reduction of oxidative stress. It may also influence cellular signaling pathways, including those involved in inflammation and cell proliferation. Uses and applications of Apigenin 7-O-(2G-rhamnosyl)gentiobioside are primarily focused on the fields of phytochemistry and pharmacognosy. Researchers study these compounds for their potential health benefits, including anti-inflammatory, antioxidant, and anticancer effects. Additionally, they may be used as bioactive markers in the analysis of plant extracts, contributing to the understanding of the therapeutic potential of traditional medicinal plants.

Clinopodiside A is a bioactive compound, which is a natural triterpenoid saponin isolated from plants belonging to the genus Clinopodium. This compound is sourced specifically from Clinopodium chinense, a species traditionally utilized in herbal medicine. The mode of action of Clinopodiside A primarily involves modulation of cellular processes through its interaction with cell membranes and signaling pathways, leading to various biological effects. Clinopodiside A is primarily researched for its potential therapeutic properties, including anti-inflammatory, antioxidant, and anticancer activities. Studies suggest that it may inhibit the growth of certain cancer cells by inducing apoptosis and disrupting signaling pathways critical for cell survival. Additionally, its anti-inflammatory effects are linked to the suppression of pro-inflammatory cytokines, making it a candidate for conditions characterized by excessive inflammation. Researchers continue to explore its potential in developing new pharmacological agents for diverse medical applications.

Naringin Dihydrochalcone is an artificial sweetener derived from naringin. Naringin is a major flavanone glycoside obtained from tomatoes, grapefruits, and many other citrus fruits. Naringin exhibits biological properties such as antioxidant, anti-inflammatory, and antiapoptotic activities. Naringin suppresses NF-κB signaling pathway.

Hinokiflavone has significant cytotoxicity, it has inhibition of MMP-9.

Anti-inflammatory; antioxidant; anti-cancer agent; neuroprotective

a-Glucosylrutin is a flavonoid glycoside derivative, which is synthesized from rutin, a natural flavonoid extracted from plants such as buckwheat and citrus fruits, using an enzymatic glucosylation process. The incorporation of glucose enhances its stability and solubility compared to its parent compound, rutin. The mode of action of a-Glucosylrutin involves its antioxidant activity, where it scavenges free radicals and reduces oxidative stress at the cellular level. This activity mitigates damage to cells and tissues, which is crucial in various oxidative stress-related conditions. In terms of applications, a-Glucosylrutin is extensively utilized in cosmetic formulations due to its ability to protect skin cells, reduce inflammation, and enhance skin health. Its protective properties are also researched for potential roles in preventing chronic diseases related to oxidative damage. Researchers are exploring its applications in pharmaceuticals and nutraceuticals as well, given its enhanced bioavailability and efficacy as an antioxidant agent. Its multifunctional nature makes it a subject of interest for further scientific exploration in various biomedical fields.